FDA announces new sunscreen rules
The US Food and Drug Administration (FDA) has announced significant changes to sunscreen products that will help consumers decide how to buy and use sunscreen, and allow them to more effectively protect themselves and their families from sun-induced damage.
NICE guideline process earns international praise
An editorial published in the US journal Annals of Internal Medicine 7th June 2011 reviews the UK National Institute for Health and Clinical Excellence (NICE) guidelines for prevention of delirium. The US Institute of Medicine (IOM) has proposed a series of standards that should be met by all guidelines in order for them to be considered ‘trustworthy’ by clinicians. This editorial describes the NICE process as coming “close to meeting the IOM's rigorous definition of trustworthy”. The journal plans to publish future NICE guidelines to aid their dissemination to a wider audience. NICE guidelines relating to dermatology can be located here.
|
Skin Moisturisation by Dermonutrition: outcomes of a dairy matrix product
Anthony V. Rawlings
Prime – International Journal of Aesthetics and Anti-Ageing Medicine, May 2011
In this review the effects of nutrients on skin condition, particularly their potential to influence or improve skin barrier function, is explored. The ingredients of the dairy product include borage oil, green tea, vitamin E, and the probiotics Lactobacillus casei, Lactobacillus bulgaricus, and Streptococcus thermophilus.
For a FREE subscription to PRIME – International Journal of Aesthetics and Anti-Ageing Medicine click here.
Extensive long-standing chromomycosis due to Fonsecaea pedrosoi: three cases with relevant improvement under voriconazole therapy
Paulo Ricardo Criado, Mariana Figueiroa Careta, Neusa Y. S. Valente, José Eduardo Costa Martins, Evandro A. Rivitti, Ricardo Spina & Walter Beld A Jr
Journal of Dermatological Treatment, June 2011
This is the first report with a case series of chromomycosis treated with voriconazole. It concludes that, despite its high cost, voriconazole is a safe and possibly promising drug for use on extensive chromomycosis refractory to conventional treatment.
Wound healing: a new approach to the topical wound care
Ferdi Öztürk & Aylin Türel Ermertcan
Cutaneous and Ocular Toxicology, June 2011
In this study, the authors break down the wound healing process and review the different methods used in the management of nonhealing wounds.
|
|
|
Belatacept
|
60 reactions
|
|
Ezogabine*
|
52 reactions
|
|
Rilpivirine
|
25 reactions
|
|
Telaprevir
|
18 reactions
|
*See D.E.R.M. Spotlight below
Litt's D.E.R.M. Database aims to be the world’s most comprehensive resource on dermatological reactions to drugs. The database is constantly updated with the very latest information.
Help us, help you: If you find a drug or a reaction that needs to be added to the database, then please let us know. Email the editorial team at support@drugeruptiondata.com.
|
Ezogabine
The FDA approved Potiga™ (ezogabine) tablets on 13th June 2011 as an adjuctive treatment of partial-onset seizures in adults. Partial seizures are the most common type of seizure seen in people with epilepsy. Epilepsy is a brain disorder in which there is abnormal or excessive activity of nerve cells in the brain. Partial seizures affect only a limited or localized area of the brain, but can spread to other parts of the brain. Seizures cause a wide range of symptoms, including repetitive limb movements (spasms), unusual behavior, and generalized convulsions with loss of consciousness.
Outside of the US, ezogabine is known as retigabine (brand name Trobalt™), and received marketing authorization in the European Union on 28th March 2011.
|
Generic Name
|
Ezogabine
|
|
Trade Names
|
Potiga™, Trobalt™
|
|
Indication
|
Epilepsy
|
|
Class
|
Potassium channel opener
|
|
Pregnancy Category
|
C
|
|
Half-life
|
7-11 hours
|
|
Potentially Hazardous Interactions
|
Alcohol; Carbamazepine; Digoxin; Phenytoin
|
|
Reactions
|
See www.drugeruptiondata.com for a list of 55 possible adverse reactions and links to relevant references on PubMed
|
|
Illustrated Manual of Injectable Fillers: a technical guide to the volumetric approach to whole body rejuvenation
Edited by Neil Sadick, Paul Carniol, Deborshi Roy and Luitgard Wiest
Be equipped to prevent and properly treat potential complications of filler usage and provide patients with safe, reliable, and aesthetically pleasing results.
The book retains all the features that made its predecessor so successful, such as detailed anatomic drawings, a review of the different formulations available and specimen forms.
The Illustrated Manual of Injectable Fillers clearly presents and evaluates the uses, limitations, and compositions of the growing variety of available fillers involved in face and body rejuvenation. Clearly organized by anatomy, this resource discusses the specific analysis, diagnosis, and treatment for each part of the body, including the upper face, midface, lower face, hands, torso, and lower extremities.
You can now save 10% by ordering before the 31th July. To take advantage of this offer or for further information, simply CLICK HERE and use Discount Code SADLIT1 in the checkout area.
|
|
Gerard O'Brien
Informa Healthcare
Telephone House,
69-77 Paul Street
London,
EC2A 4LQ
UK
|
|
TEL: +44 (0)20 7017 3758
EMAIL: gerard.obrien@informa.com
|
Best wishes,
Litt's D.E.R.M. Editorial team
support@drugeruptiondata.com
PS Register FREE to PRIME the International Journal of Aesthetics and Anti-Ageing Medicine
PRIME is the source for the latest research and technological developments in the aesthetic and anti-ageing industry, with a focus on providing expert insight into topics including non-surgical treatments, internal medicine and ground-breaking research in neurology and endocrinology. Subscribers to PRIME will benefit from an editorial board of over 40 members examining global issues, allowing them to better understand the latest technologies and applications shaping the industry and helping to make the right investment decisions for the future.
PRIME is FREE to physicians and surgeons. Register here and quote code P1106E to preview the latest issue via email!
|
|
